Pierre Caloz
Chief Operating Officer chez UNIQURE N.V.
Fortune : 616 944 $ au 31/03/2024
Profil
Pierre Caloz is currently the Chief Operating Officer at uniQure NV since 2021.
Prior to this, he worked as the SVP, GM-European Union & Asia Pacific Operations at CSL Behring NV.
Caloz completed his undergraduate degree from the University of Geneva in 1996, followed by a graduate degree from the Swiss Federal Institute of Technology in 1997.
He also holds an MBA from Ashridge Business School, which he completed in 2010.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
UNIQURE N.V.
0,25% | 01/03/2024 | 118 643 ( 0,25% ) | 616 944 $ | 31/03/2024 |
Postes actifs de Pierre Caloz
| Sociétés | Poste | Début |
|---|---|---|
| UNIQURE N.V. | Chief Operating Officer | 17/05/2021 |
Anciens postes connus de Pierre Caloz
| Sociétés | Poste | Fin |
|---|---|---|
CSL Behring NV
 CSL Behring NV BiotechnologyHealth Technology CSL Behring NV engages in the research and development of biotherapies for the treatment of rare and severe illnesses. It offers hematology, immunology, pneumology and specific medicine. The company was founded on February 15, 1995 and is headquartered in Mechelen, Belgium. | Corporate Officer/Principal | - |
Formation de Pierre Caloz
| University of Geneva | Undergraduate Degree |
| Swiss Federal Institute of Technology | Graduate Degree |
| Ashridge Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| UNIQURE N.V. | Health Technology |
| Entreprise privées | 1 |
|---|---|
CSL Behring NV
CSL Behring NV BiotechnologyHealth Technology CSL Behring NV engages in the research and development of biotherapies for the treatment of rare and severe illnesses. It offers hematology, immunology, pneumology and specific medicine. The company was founded on February 15, 1995 and is headquartered in Mechelen, Belgium. | Health Technology |
